Transactions
35
2 buys · 33 sells
Bought
$1.36M
Open market
Sold
$5.35M
Open market
Net flow
−$4M
Buys − sells
Transactions
| Insider | Role | Action | Shares | Price | Value | Trade date | Filing |
|---|---|---|---|---|---|---|---|
| Feld Michael | officer: EVP, Chief Revenue Officer | Sell | 74 | $151.94 | $11.24K | Apr 27, 2026 | Apr 28, 2026 |
| Feld Michael | officer: EVP, Chief Revenue Officer | Sell | 75 | $156.83 | $11.76K | Mar 26, 2026 | Mar 27, 2026 |
| Feld Michael | officer: EVP, Chief Revenue Officer | Sell | 75 | $181.84 | $13.64K | Feb 26, 2026 | Feb 27, 2026 |
| SCOTT BERTRAM L | director | Sell | 953 | $182.61 | $174.03K | Feb 18, 2026 | Feb 18, 2026 |
| Feld Michael | officer: EVP, CRO & Pres. Life Sciences | Sell | 75 | $202.73 | $15.2K | Jan 26, 2026 | Jan 28, 2026 |
| Garrison Michael David | officer: EVP & Pres Med.Essntl&BioPharm | Sell | 600 | $209.00 | $125.4K | Jan 15, 2026 | Jan 16, 2026 |
| Garrison Michael David | officer: EVP & Pres Med.Essntl&BioPharm | Sell | 1,010 | $206.54 | $208.61K | Jan 15, 2026 | Jan 16, 2026 |
| Feld Michael | officer: EVP, CRO & Pres. Life Sciences | Sell | 74 | $196.08 | $14.51K | Dec 26, 2025 | Dec 29, 2025 |
| Garrison Michael David | officer: EVP & Pres Med.Essntl&BioPharm | Sell | 629 | $196.03 | $123.3K | Dec 17, 2025 | Dec 17, 2025 |
| Feld Michael | officer: EVP, CRO & Pres. Life Sciences | Sell | 75 | $193.36 | $14.5K | Dec 01, 2025 | Dec 02, 2025 |
| SCOTT BERTRAM L | director | Sell | 217 | $176.58 | $38.32K | Nov 07, 2025 | Nov 07, 2025 |
| Feld Michael | officer: EVP & President, Life Sciences | Sell | 57 | $186.01 | $10.6K | Oct 27, 2025 | Oct 28, 2025 |
| Feld Michael | officer: EVP & President, Life Sciences | Sell | 58 | $181.03 | $10.5K | Sep 26, 2025 | Sep 29, 2025 |
| Fraser Claire | director | Sell | 917 | $187.50 | $171.94K | Sep 10, 2025 | Sep 11, 2025 |
| Feld Michael | officer: EVP & President, Life Sciences | Sell | 57 | $197.99 | $11.29K | Aug 22, 2025 | Aug 26, 2025 |
| HAYES GREGORY | director | Buy | 5,250 | $191.57 | $1.01M | Aug 11, 2025 | Aug 11, 2025 |
| Fraser Claire | director | Sell | 863 | $192.30 | $165.95K | Aug 08, 2025 | Aug 08, 2025 |
| Garrison Michael David | officer: EVP & President, Medical | Sell | 1,184 | $180.29 | $213.46K | Jul 18, 2025 | Jul 22, 2025 |
| Garrison Michael David | officer: EVP & President, Medical | Sell | 1 | $181.50 | $181.5 | Jul 18, 2025 | Jul 22, 2025 |
| Shan David | officer: EVP and Chief ISC Officer | Sell | 1,166 | $171.19 | $199.61K | Jun 02, 2025 | Jun 02, 2025 |
| Garrison Michael David | officer: EVP & President, Medical | Sell | 479 | $197.28 | $94.5K | Apr 09, 2025 | Apr 10, 2025 |
| Byrd Richard | officer: EVP & President Interventional | Sell | 459 | $230.00 | $105.57K | Mar 18, 2025 | Mar 19, 2025 |
| Byrd Richard | officer: EVP & President Interventional | Sell | 1,940 | $224.91 | $436.33K | Mar 12, 2025 | Mar 13, 2025 |
| SCOTT BERTRAM L | director | Sell | 700 | $227.99 | $159.59K | Feb 12, 2025 | Feb 12, 2025 |
| Henderson Jeffrey William | director | Buy | 1,500 | $233.62 | $350.43K | Feb 10, 2025 | Feb 10, 2025 |
| Neal Shana Carol | officer: EVP and Chief People Officer | Sell | 787 | $240.00 | $188.88K | Jan 21, 2025 | Jan 22, 2025 |
| Shan David | officer: EVP and Chief ISC Officer | Sell | 500 | $240.00 | $120K | Jan 21, 2025 | Jan 22, 2025 |
| Garrison Michael David | officer: EVP & President, Medical | Sell | 597 | $236.51 | $141.2K | Jan 17, 2025 | Jan 21, 2025 |
| Neal Shana Carol | officer: EVP and Chief People Officer | Sell | 788 | $235.00 | $185.18K | Jan 07, 2025 | Jan 10, 2025 |
| Garrison Michael David | officer: EVP & President, Medical | Sell | 2,838 | $223.33 | $633.81K | Dec 19, 2024 | Dec 20, 2024 |
| Goette Roland | officer: EVP and President, EMEA | Sell | 638 | $219.03 | $139.74K | Dec 09, 2024 | Dec 10, 2024 |
| Neal Shana Carol | officer: EVP and Chief People Officer | Sell | 1,000 | $220.49 | $220.49K | Dec 06, 2024 | Dec 10, 2024 |
| Goette Roland | officer: EVP and President, EMEA | Sell | 4,483 | $221.01 | $990.79K | Dec 06, 2024 | Dec 10, 2024 |
| Shan David | officer: EVP and Chief ISC Officer | Sell | 1,500 | $220.25 | $330.38K | Dec 05, 2024 | Dec 06, 2024 |
| Spoerel Thomas J | officer: SVP,Controller&Chief Acct Off | Sell | 300 | $239.31 | $71.79K | Jun 10, 2024 | Jun 11, 2024 |
By insider
- Garrison Michael David−$1.54Mofficer: EVP & Pres Med.Essntl&BioPharm0B · 8S
- Goette Roland−$1.13Mofficer: EVP and President, EMEA0B · 2S
- HAYES GREGORY+$1.01Mdirector1B · 0S
- Shan David−$649.98Kofficer: EVP and Chief ISC Officer0B · 3S
- Neal Shana Carol−$594.55Kofficer: EVP and Chief People Officer0B · 3S
- Byrd Richard−$541.9Kofficer: EVP & President Interventional0B · 2S
- SCOTT BERTRAM L−$371.94Kdirector0B · 3S
- Henderson Jeffrey William+$350.43Kdirector1B · 0S
- Fraser Claire−$337.89Kdirector0B · 2S
- Feld Michael−$113.25Kofficer: EVP, Chief Revenue Officer0B · 9S
- Spoerel Thomas J−$71.79Kofficer: SVP,Controller&Chief Acct Off0B · 1S
Beneficial ownership filings
Schedule 13D / 13G — investors holding more than 5% of BDX-US.
DB · acquisition_ownership3
Top 10 holders · 8 quarters
13F position evolutionNo 13F history in
institutional_holders for BDX-US.